You are here: Industry Insights > Biologics

News List

HJB and Ansun Biopharma Enter Biologics Collaboration contractpharma
September 02, 2020
CMC development and manufacturing partnership expecting to submit an IND application in 2021.
CPI Partners with Perceptive Engineering and FujiFilm Diosynth Biotechnologies contractpharma
August 14, 2020
CPI, an independent technology innovation center, is partnering with Perceptive Engineering and FujiFilm Diosynth Biotechnologies.
Wacker Invests in Amsterdam Site contractpharma
July 30, 2020
Wacker, the Munich-based chemicals group, is investing in its production facilities for biologics, LMPs (live microbial products) and vaccines at its Amsterdam site.
Catalent Expands Clinical Manufacturing Operations contractpharma
July 22, 2020
Invests $30 million to create European clinical manufacturing center of excellence in Limoges, France.
Bionova Begins Construction of New Manufacturing Center contractpharma
July 15, 2020
The 36,000 sq. ft. facility will be located within the company’s headquarters.
PCI Pharma Services Completes Biotech CoE contractpharma
July 01, 2020
PCI is also investing to expand its global packaging capabilities for biologics at its operations in Ireland.
ChemPartner Expands Biologics Capabilities contractpharma
June 17, 2020
Makes additional investments in biologics from research to manufacturing capabilities.
Catalent Completes $14M Biologics Packaging Expansion contractpharma
April 24, 2020
Adds 15,000 square feet of packaging infrastructure to biologics and sterile manufacturing at its Bloomington, IN facility.
WuXi Biologics Completes Weather-Tight Seal of its Biologics Manufacturing Facility in Ireland Wuxi Biologics
March 11, 2020
WuXi Biologics announced that it has completed the weather-tight seal of its biologics drug substance manufacturing facility on the Dundalk Campus in Ireland on schedule, which significantly symbolizes the start of the company’s global biomanufacturing ne
Biologics and generics reported to save NHS £700m europeanpharmaceuticalreview
September 03, 2019
An NHS-wide plan to use more generic and biologic products has reportedly saved the healthcare provider £700 million since 2016.

Previous page 1 2 3 4 5 6 7 8 9 Next page